Cite
Munkhaugen J, Sverre E, Peersen K, et al. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020;doi: 10.1177/2047487320923187.
Munkhaugen, J., Sverre, E., Peersen, K., Kristiansen, O., Gjertsen, E., Gullestad, L., & Erik Otterstad, J. (2020). Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. European journal of preventive cardiology, . https://doi.org/10.1177/2047487320923187
Munkhaugen, John, et al. "Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?." European journal of preventive cardiology vol. (2020). doi: https://doi.org/10.1177/2047487320923187
Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020 May 13; doi: 10.1177/2047487320923187. Epub 2020 May 13. PMID: 33611511.
Copy
Download .nbib